Virtual Medicinal Product (VMP)
-
Tobramycin 300mg/5ml nebuliser liquid ampoules
Name Details
Current Name
Tobramycin 300mg/5ml nebuliser liquid ampoules
|
Start Date
01-02-2010
|
End Date
|
Previous Name
Tobramycin 60mg/ml nebuliser liquid 5ml ampoules
|
Start Date
24-03-2003
|
End Date
31-01-2010
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Nebuliser liquid
- Ontology Form/Route
- solutionnebuliser.inhalation
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01GB01
BNF |
Current BNF
05010400
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010400
|
Start Date
02-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
4145111000001102 |
24-03-2003 |
|
VMP Ingredients
VMP ingredients table
Tobramycin |
Based on Ingredient Substance |
|
60 mg |
1 ml |
Name
Tobramycin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
60
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Tobramycin
-
VMP
(Current) Tobramycin 300mg/5ml nebuliser liqui...
Virtual Medicinal Product Pack (VMPP) Information